IL10 and respiratory failure: Indeed, it has recently been reported that abrupt cessation of A1AT augmentation therapy for patients with AATD resulted in marked increases in levels of these specific proinflammatory cytokines, a loss of IL-10, and subsequent progression to respiratory failure [35].